University of Notre Dame du Lac’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-272,476
Closed -$2.89M 86
2018
Q3
$2.89M Buy
272,476
+98,494
+57% +$1.12M 0.54% 56
2018
Q2
$2.36M Buy
173,982
+35,551
+26% +$553K 0.46% 62
2018
Q1
$2.46M Sell
138,431
-66,169
-32% -$1.12M 0.46% 66
2017
Q4
$2.57M Buy
204,600
+12,881
+7% +$187K 0.53% 62
2017
Q3
$3.65M Buy
191,719
+38,368
+25% +$585K 1.02% 52
2017
Q2
$2.32M Buy
+153,351
New +$2.32M 0.68% 68

Other funds holding EPZM

University of Notre Dame du Lac's EPZM Position: Q4 2018 in Review

University of Notre Dame du Lac sold out of Epizyme, Inc (EPZM) in Q4 2018, closing a stake of 272,476 shares — an estimated $2.89M sold.

University of Notre Dame du Lac first reported a position in EPZM in Q2 2017 and held it in 6 quarters. The position peaked at $3.65M in Q3 2017. 105 funds tracked by Wall St. Rank hold EPZM as of Q4 2018.

  • University of Notre Dame du Lac reported no remaining Epizyme, Inc position as of Q4 2018 after selling out during the quarter.
  • University of Notre Dame du Lac sold 272,476 Epizyme, Inc shares in Q4 2018, an estimated $2.89M.
  • University of Notre Dame du Lac first reported a position in Epizyme, Inc in Q2 2017 and held it in 6 quarters.
  • University of Notre Dame du Lac's Epizyme, Inc position peaked at $3.65M in Q3 2017.
  • 105 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2018.

Based on University of Notre Dame du Lac's 13F filing for Q4 2018, filed 13 Feb 2019.